| MET |
MET: Hepatocyte growth factor receptor precursor |
APC |
IPI00215877 |
0.858 |
Evidence |
|
| C8G |
C8G: Complement component C8 gamma chain precursor |
SLAMF1 |
SLAMF1, SLAM: Signaling lymphocytic activation molecule precursor |
0.858 |
Evidence |
|
| C8G |
C8G: Complement component C8 gamma chain precursor |
CD59 |
CD59, MIC11, MIN1, MIN2, MIN3, MSK21: CD59 glycoprotein precursor |
0.858 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
MARK2 |
IPI00718858 |
0.858 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
MNAR |
PELP1, HMX3, MNAR: Proline-, glutamic acid- and leucine-rich protein 1 |
0.858 |
Evidence |
|
| SERPINA7 |
SERPINA7, TBG: Thyroxine-binding globulin precursor |
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
0.858 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
0.858 |
Evidence |
|
| SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
F3 |
F3: Tissue factor precursor |
0.858 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
ITGA2B |
ITGA2B, GP2B, ITGAB: Integrin alpha-IIb precursor |
0.858 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
ABCG2 |
ABCG2, ABCP, BCRP, BCRP1, MXR: ATP-binding cassette sub-family G member 2 |
0.858 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
F3 |
F3: Tissue factor precursor |
0.858 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
0.858 |
Evidence |
|
| CD3D |
CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor |
MICAL-L1 |
MICALL1, KIAA1668, MIRAB13: MICAL-like protein 1 |
0.858 |
Evidence |
|
| CD3D |
CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor |
IRS1 |
IRS1: Insulin receptor substrate 1 |
0.858 |
Evidence |
|
| CD3D |
CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor |
MYL9 |
MYL9, MLC2, MRLC1, MYRL2: Myosin regulatory light chain 2, smooth muscle isoform |
0.858 |
Evidence |
|
| CD3D |
CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor |
IL1RN |
IL1RN, IL1F3, IL1RA: Interleukin-1 receptor antagonist protein precursor |
0.858 |
Evidence |
|
| PROC |
PROC: Vitamin K-dependent protein C precursor |
ZAK |
MLTK, ZAK, HCCS4: Mitogen-activated protein kinase kinase kinase MLT |
0.858 |
Evidence |
|
| PROC |
PROC: Vitamin K-dependent protein C precursor |
CD3D |
CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor |
0.858 |
Evidence |
|
| MMP1 |
MMP1, CLG: Interstitial collagenase precursor |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
0.858 |
Evidence |
|
| MMP1 |
MMP1, CLG: Interstitial collagenase precursor |
TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
0.858 |
Evidence |
|
| RNASE4 |
ANG, RNASE5: Angiogenin precursor |
IFNGR1 |
IFNGR1: Interferon-gamma receptor alpha chain precursor |
0.858 |
Evidence |
|
| RNASE4 |
ANG, RNASE5: Angiogenin precursor |
F3 |
F3: Tissue factor precursor |
0.858 |
Evidence |
|
| RNASE4 |
ANG, RNASE5: Angiogenin precursor |
CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
0.858 |
Evidence |
|
| TNF |
TNF, TNFA, TNFSF2: Tumor necrosis factor precursor |
CPA2 |
CPA2: Carboxypeptidase A2 precursor |
0.858 |
Evidence |
|
| TNF |
TNF, TNFA, TNFSF2: Tumor necrosis factor precursor |
CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
0.858 |
Evidence |
|